Indometacin/l-menthol - Kowa Research Institute
Alternative Names: K-285; l-menthol/indometacin - KowaLatest Information Update: 14 Oct 2022
At a glance
- Originator Kowa Research Institute
- Class Analgesics; Chlorobenzenes; Cyclohexanols; Indoles; Monoterpenes; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 14 Oct 2022 No development reported - Phase-II for Acute pain (In volunteers) in USA (Topical) (Kowa Research Institute pipeline, October 2022)
- 09 Aug 2021 Kowa Research Institute terminates a phase II trial in Acute pain (In volunteers) in USA (Topical), due to business decision (NCT04484428)
- 15 Aug 2020 Phase-II clinical trials in Acute pain (In volunteers) in USA (Topical) (NCT04484428)